Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's ColonCancerCheck program

Implementation Science

Volumn 10, Issue 1, 2015, Pages

  Stock, David ^a   Rabeneck, Linda ^b,c,d,e,f   Baxter, Nancy N ^b,d,e,g   Paszat, Lawrence F ^c,d   Sutradhar, Rinku ^c,d   Yun, Lingsong ^d   Tinmouth, Jill ^a,b,d,e,f  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f CANCER CARE ONTARIO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Colonoscopy; Colorectal cancer; Fecal occult blood test; Program evaluation; Screening

Indexed keywords

AGED; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; HUMAN; MALE; MIDDLE AGED; OCCULT BLOOD; ONTARIO; PATIENT ATTITUDE; POSTAL MAIL; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; REMINDER SYSTEM; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; ONTARIO; PATIENT ACCEPTANCE OF HEALTH CARE; POSTAL SERVICE; PROSPECTIVE STUDIES; REMINDER SYSTEMS;

EID: 84925326955     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-015-0226-0     Document Type: Article

References (26)

1. Canadian Cancer Society's Advisory Committee on Cancer Statistics: Canadian Cancer Statistics 2013. Canadian Cancer Society 2013.
2. Heresbach D, Manfredi S, D'Halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006;18:427-33.
3. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;1.
4. Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, et al. Ontario's ColonCancerCheck: results from Canada's first province-wide colorectal cancer screening program. Cancer Epidemiol Biomarkers Prev. 2014;23:508-15.
5. Statistics Canada. Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (CANSIM Table 051-0001). Ottawa: Statistics Canada; 2010 [accessed June 24 2014].
6. Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut. 2012;61:1439-46.
7. Leuraud K, Jezewski-Serra D, Saline E. Evaluation épidémiologique du programme de dépistage organisé du cancer colorectal en France: Première évaluation depuis la généralisation du programme pour 46 départements sur la période 2008-2009. Saint-Maurice. Institut de veille sanitaire; 2012. 29 p.
8. Paterson WG, Depew WT, Pare P, Petrunia D, Switzer C, van Zanten SJV, et al. Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol. 2006;20:411-23.
9. Correia AJ, Rabeneck L, Paszat LF, Baxter NN, Sutradhar R, Tinmouth J. Factors associated with lack of follow-up following a positive FOBT. Gastroenterology. 2011;140:S-51.
10. Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41:495-501.
11. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96-102.
12. Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011;49:932-9.
13. Jee SH, Cabana MD. Indices for continuity of care: a systematic review of the literature. Med Care Res Rev MCRR. 2006;63:158-88.
14. Jaakkimainen L, Klein-Geltink JE, Guttmann A, Barnsley J, Zagorski BM, Kopp A, et al. Indicators of primary care based on administrative data. In: Primary Care in Ontario: ICES Atlas. Toronto: Institute for Clinical Evaluative Sciences; 2006.
15. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health. 1981;71:38-46.
16. ColonCancerCheck Update: Spring. 2010. [https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=76232 ]
17. Myers RE, Turner B, Weinberg D, Hyslop T, Hauck WW, Brigham T, et al. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med. 2004;38:375-81.
18. Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M. Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med. 2011;26:691-7.
19. Larson MF, Ko CW, Dominitz JA. Effectiveness of a provider reminder on fecal occult blood test follow-up. Dig Dis Sci. 2009;54:1991-6.
20. Singh H, Kadiyala H, Bhagwath G, Shethia A, El-Serag H, Walder A, et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol. 2009;104:942-52.
21. Van Kleek E, Liu S, Conn LM, Hoadley A, Ho SB. Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests. J Healthc Qual. 2010;32:62-9.
22. Miglioretti DL, Rutter CM, Bradford SC, Zauber AG, Kessler LG, Feuer EJ, et al. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care. 2008;46:S91-6.
23. Cha JM, Lee JI, Joo KR, Shin HP, Park JJ. Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive fecal immunochemical test. Dig Dis Sci. 2011;56:3137-42.
24. Zorzi M, Giorgi Rossi P, Cogo C, Falcini F, Giorgi D, Grazzini G, et al. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes. Prev Med. 2014;65C:70-6.
25. Health Quality Ontario. Electronic tools for health information exchange: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13:1-76.
26. Swan H, Siddiqui AA, Myers RE. International colorectal screening programs: population contact strategies, testing methods and screening rates. Pract Gastroenterol. 2012;36:8.